IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT06974812 · RECRUITING
Trial details
- NCT number
- NCT06974812
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-18
- Primary completion
- 2026-06-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.